Drug
Ad4 Mgag
Ad4 Mgag: highest development phase Phase 1, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ad4-mgag NCT02771730 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Ad4 Mgag on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.